Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
Consider This from NPR
NPR
4.2 • 6.2K Ratings
🗓️ 3 February 2021
⏱️ 12 minutes
🧾️ Download transcript
Summary
Combined with the two vaccines currently in circulation, the U.S. could have three vaccines that are all highly effective at preventing death or hospitalization due to COVID-19.
Despite that promising news, NPR's Richard Harris reports on why the journey to herd immunity still won't be easy.
And Rae Ellen Bichelle goes inside a Colorado long-term care facility that has vaccinated nearly all of its residents. They say the initial steps to a return to normalcy feel great.
Additional reporting in this episode on the spread of coronavirus variants from NPR's Allison Aubrey.
In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.
Email us at considerthis@npr.org.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Transcript
Click on a timestamp to play from that location
| 0:00.0 | It looks like a third vaccine is on the way. |
| 0:03.7 | It's only with the collaboration of all of the pharmaceutical companies here that it will |
| 0:09.2 | be able to combat this disease in the world. And that's where our vaccine will have its place. |
| 0:14.4 | Dr. Paul Stoffels is the Chief Scientific Officer at Johnson and Johnson. He spoke to NPR this |
| 0:20.0 | past week about his company's vaccine. New data show it appears to be 85% effective at |
| 0:26.4 | preventing severe disease and 100% effective at preventing hospitalization and death. |
| 0:32.4 | We will submit our file in the course of next week and then of course the FDA as well as |
| 0:37.2 | other authorities will have to do the evaluation work. |
| 0:40.4 | The FDA could authorize the vaccine as early as this month. |
| 0:45.5 | Now you may have heard that when it comes to preventing moderate cases of COVID-19, |
| 0:50.2 | Johnson and Johnson's shot is about 65% effective. That's compared to about 95% for the Pfizer and |
| 0:58.2 | Moderna shots. If this had occurred in the absence of a prior announcement and implementation of |
| 1:04.8 | 94-95% efficacy, one would have said this was an absolutely spectacular result. |
| 1:11.3 | Dr. Anthony Fauci pointed out this past week, the Johnson and Johnson efficacy rate is still high |
| 1:17.2 | and the vaccine has a lot of upside. It only requires one shot instead of two. It doesn't require |
| 1:24.0 | extreme refrigeration and the company is capable of making billions of doses. |
| 1:28.7 | That will alleviate so much of the stress in human suffering and death in this epidemic that we're |
| 1:35.0 | seeing. This plus, if you others that we have, that actually prevent severe disease to a very |
| 1:42.2 | substantial degree. Consider this. COVID-19 vaccines continue to be highly effective at preventing |
| 1:50.1 | hospitalization and death, but reaching the ultimate goal of herd immunity won't be easy. |
| 1:57.5 | From NPR, I'm Audit Cornish. It's Wednesday, February 3rd. |
| 2:04.6 | This message comes from NPR's sponsor, BYU Radio, with the podcast top of mind. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.